Erika Parasido

608 total citations
16 papers, 348 citations indexed

About

Erika Parasido is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erika Parasido has authored 16 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erika Parasido's work include Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Lanthanide and Transition Metal Complexes (2 papers). Erika Parasido is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Lanthanide and Transition Metal Complexes (2 papers). Erika Parasido collaborates with scholars based in United States, Italy and Ukraine. Erika Parasido's co-authors include Maria Laura Avantaggiati, Amrita K. Cheema, Giuseppe Giaccone, Garrett T. Graham, Chris Albanese, Christopher Albanese, Olga Rodriguez, Emanuel F. Petricoin, Chunling Yi and Patricia L. Foley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and ACS Applied Materials & Interfaces.

In The Last Decade

Erika Parasido

15 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika Parasido United States	11	195	108	80	45	42	16	348
Debora Grasso Belgium	6	312 1.6×	246 2.3×	68 0.8×	32 0.7×	28 0.7×	6	440
Johan Swinnen Belgium	7	131 0.7×	107 1.0×	47 0.6×	38 0.8×	33 0.8×	16	330
Xiongjian Rao United States	6	291 1.5×	120 1.1×	73 0.9×	20 0.4×	21 0.5×	11	396
Sunsook Hwang South Korea	10	187 1.0×	169 1.6×	91 1.1×	57 1.3×	19 0.5×	15	367
Wen‐Lian Chen China	10	262 1.3×	186 1.7×	74 0.9×	48 1.1×	17 0.4×	20	419
Labiq H. Syed United States	9	275 1.4×	270 2.5×	50 0.6×	45 1.0×	64 1.5×	13	461
Satoshi Owada Japan	10	233 1.2×	162 1.5×	68 0.8×	72 1.6×	13 0.3×	17	387
Myriam Y. Hsu Italy	8	198 1.0×	121 1.1×	67 0.8×	23 0.5×	20 0.5×	11	372
Xinbao Zhao China	9	176 0.9×	94 0.9×	110 1.4×	22 0.5×	31 0.7×	12	327

Countries citing papers authored by Erika Parasido

Since Specialization

Citations

This map shows the geographic impact of Erika Parasido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Parasido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Parasido more than expected).

Fields of papers citing papers by Erika Parasido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Parasido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Parasido. The network helps show where Erika Parasido may publish in the future.

Co-authorship network of co-authors of Erika Parasido

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Parasido. A scholar is included among the top collaborators of Erika Parasido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Parasido. Erika Parasido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Parasido, Erika, Mariaelena Pierobon, Yu Chen, et al.. (2024). Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging. Cell Cycle. 23(7-8). 767–778.

Issa, Naiem T., Eric Glasgow, Ivana Peran, et al.. (2022). A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer. Ecotoxicology and Environmental Safety. 233. 113330–113330. 8 indexed citations

Rodriguez, Olga, Christopher Albanese, Erika Parasido, et al.. (2021). Paramagnetic Mn₈Fe₄-co-Polystyrene Nanobeads as a Potential T₁–T₂ Multimodal Magnetic Resonance Imaging Contrast Agent with In Vivo Studies. ACS Applied Materials & Interfaces. 13(33). 39042–39054. 10 indexed citations

Tatman, Philip D., Michael W. Graner, Kevin O. Lillehei, et al.. (2020). Pan-cancer analysis to identify a novel class of glucocorticoid and androgen receptor antagonists with potent anti-tumor activity.. Journal of Clinical Oncology. 38(15_suppl). e15663–e15663. 4 indexed citations

Graham, Garrett T., Erika Parasido, Patricia L. Foley, et al.. (2020). Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death and Differentiation. 27(7). 2143–2157. 84 indexed citations

Naeem, Aisha, Sivanesan Dakshanamurthy, Erika Parasido, et al.. (2020). Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells. The Prostate. 80(14). 1233–1243. 10 indexed citations

Parasido, Erika, Jonathan R. Brody, Jordan M. Winter, et al.. (2019). Abstract 1283: Targeting c-MYC and MAPK pathway to overcome pancreatic cancer drug resistance. Cancer Research. 79(13_Supplement). 1283–1283. 3 indexed citations

Pornrungroj, Chanon, Yi‐Chien Lee, Erika Parasido, et al.. (2019). Paramagnetic Clusters of Mn₃(O₂CCH₃)₆(Bpy)₂ in Polyacrylamide Nanobeads as a New Design Approach to a T₁–T₂ Multimodal Magnetic Resonance Imaging Contrast Agent. ACS Applied Materials & Interfaces. 11(20). 18153–18164. 11 indexed citations

Ihemelandu, Chukwuemeka, Aisha Naeem, Erika Parasido, et al.. (2019). Clinicopathologic and Prognostic Significance of LGR5, a Cancer Stem Cell Marker in Patients With Colorectal Cancer. PubMed. 8(4). CRC11–CRC11. 12 indexed citations

10.

Fernandez, Harvey R., Garrett T. Graham, Rebecca B. Riggins, et al.. (2018). The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death and Differentiation. 25(7). 1239–1258. 99 indexed citations

11.

Naeem, Aisha, Erika Parasido, Deborah L. Berry, et al.. (2017). Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells. Oncotarget. 9(2). 2193–2207. 16 indexed citations

12.

Parasido, Erika, Alessandra Silvestri, Vincenzo Canzonieri, et al.. (2016). Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine. Oncotarget. 8(30). 48534–48544. 6 indexed citations

13.

Ao, Zheng, Erika Parasido, Siddarth Rawal, et al.. (2015). Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications. Lab on a Chip. 15(22). 4277–4282. 21 indexed citations

14.

Waye, Sarah, Aisha Naeem, Erika Parasido, et al.. (2015). The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging. 7(10). 854–867. 18 indexed citations

15.

Pierobon, Mariaelena, Alessandra Silvestri, Alexander I. Spira, et al.. (2014). Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab. Journal of Proteome Research. 13(6). 2846–2855. 25 indexed citations

16.

Silvestri, Annalisa De, Elisa Pin, A. Huijbers, et al.. (2013). Individualized therapy for metastatic colorectal cancer. Journal of Internal Medicine. 274(1). 1–24. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact